The global nucleic acid isolation and purification market are growing at 9.1% CAGR owing to technological development, increasing R&D activities, rising automation. Moreover, the increasing adoption across a wide range of applications in genetic engineering, life science research, forensic, diagnostics such as STDs, congenital anomalies, cancer will fuel the growth in the market. The increasing platform for clinical diagnostics, growth in genomics, and enzymology-based research, precision medicine will fuel the growth in the market. Nevertheless, the innovation of new applications like molecular diagnostic testing, expression analysis, and genotyping will create promising opportunities in the global nucleic acid isolation and purification market.

The COVID-19 pandemic has a positive impact on the global nucleic acid isolation and purification market as companies are focused to develop specific assays and kits to rapidly detect SARS-CoV-2. Omega Bio-Tek launched Mag-Bind Viral RNA Xpress Kit to provide efficient and rapid isolation of viral RNA. Moreover, the company projected that it has a production capacity of 6 million tests per month.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/nucleic-acid-isolation-and-purification-market/request-sample

Based on product, the kits dominate the global nucleic acid isolation and purification market owing to its low cost and easy adoption of kits in various applications like gene sequencing, molecular diagnostics, and gene cloning.

The increasing demand for high-quality, tremendously pure nucleic acid like DNA and RNA is needed in a variety of research and clinical applications that will fuel the growth in the global nucleic acid isolation and purification market. Furthermore, nucleic acid isolation decreases nucleic acid loss, helps in processing samples in minimum time, and improves the effectiveness and efficiency of the laboratory. Moreover, the pharmaceutical and biotech industries require pure nucleic acids, development in genotyping will fuel the growth in the global nucleic acid isolation and purification market.

North America dominates the global nucleic acid isolation and purification market owing to the substantial R&D expenditure in biotech and pharmaceutical companies, technological development, and support by the government will propel the growth in the region.

Agilent Technologies has accelerated the use of PD-L1 IHC 22C3 pharmDx to strengthen its presence in the European Testing and Diagnostic market.
The prominent players in the global nucleic acid isolation and purification industry include Thermo Fisher Scientific, F. Hoffman-La Roche, Danaher Corporation, Qiagen N.V., Illumina, Agilent Technologies, Merck KGaA, Promega Corporation, Bio-Rad Laboratories, and GE Healthcare.

Source: VynZ Research